Document Detail


Pathological subthalamic nucleus oscillations in PD: can they be the cause of bradykinesia and akinesia?
MedLine Citation:
PMID:  19460368     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is growing evidence that Parkinson's disease (PD) is associated with pathological synchronous oscillatory activity in the basal ganglia. These synchronized oscillations primarily occur in the 11-30 Hz range, the so-called beta band. Studies of local field potential activity in the subthalamic nucleus (STN) of PD patients suggest that exaggerated beta band oscillatory activity can disrupt function and, in particular, may contribute to slowness of movement. It has been previously shown that the degree of beta oscillatory activity in the STN of PD patients correlates with the patients' benefit from dopaminergic medications, but not with baseline motor deficits. In a paper that was recently published in Experimental Neurology, [Kuhn A.A., Tsui A., Aziz T., Ray N., Brucke C., Kupsch A., Schneider G.H., Brown P., 2009. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp. Neurol. 215, 380-387.] the authors further establish that the degree of suppression of beta oscillations in the STN by dopaminergic medications can predict the level of improvement in bradykinesia and rigidity but not tremor. This commentary reviews some of the recent findings on beta oscillatory activity in PD and highlights the possible role of these pathological oscillations in mediating PD symptoms.
Authors:
Moran Weinberger; William D Hutchison; Jonathan O Dostrovsky
Related Documents :
12880648 - Anxiety sensitivity in first-degree relatives of patients with panic disorder.
10565698 - Tolcapone: a novel approach to parkinson's disease.
17878638 - Transcranial sonography of the substantia nigra in japanese patients with parkinson's d...
15036168 - Hand rhythmic tapping and timing in parkinson's disease.
22658548 - Comparison of abdominal bloating severity between irritable bowel syndrome patients wit...
20690018 - Surgical approaches to epicardial pacemaker placement: does pocket location affect lead...
Publication Detail:
Type:  Comment; Journal Article; Review     Date:  2009-05-19
Journal Detail:
Title:  Experimental neurology     Volume:  219     ISSN:  1090-2430     ISO Abbreviation:  Exp. Neurol.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-18     Completed Date:  2009-09-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370712     Medline TA:  Exp Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  58-61     Citation Subset:  IM    
Affiliation:
Department of Physiology, University of Toronto, Toronto, ON, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Action Potentials / drug effects,  physiology
Akinetic Mutism / drug therapy,  physiopathology
Antiparkinson Agents / pharmacology
Biological Clocks / drug effects,  physiology*
Dopamine Agents / pharmacology
Humans
Hypokinesia / drug therapy,  physiopathology
Parkinson Disease / drug therapy,  physiopathology*
Subthalamic Nucleus / anatomy & histology,  physiopathology*
Synaptic Transmission / drug effects,  physiology
Chemical
Reg. No./Substance:
0/Antiparkinson Agents; 0/Dopamine Agents
Comments/Corrections
Comment On:
Exp Neurol. 2009 Feb;215(2):380-7   [PMID:  19070616 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  SPIN90-IRSp53 complex participates in Rac-induced membrane ruffling.
Next Document:  Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinso...